Early adverse events as predictors of 1-year mortality during mechanical circulatory support

Journal of Heart and Lung Transplantation

Volumn 29, Issue 9, 2010, Pages 981-988

  Genovese, Elizabeth A ^a   Dew, Mary Amanda ^a   Teuteberg, Jeffrey J ^b   Simon, Marc A ^b   Bhama, Jay K ^a,b   Bermudez, Christian A ^a,b   Lockard, Kathleen L ^a   Winowich, Steve ^a   Kormos, Robert L ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Heart failure; Mechanical circulatory support; Mortality; Outcomes

Indexed keywords

ADULT; ADVERSE OUTCOME; AGED; ARTICLE; ASSISTED CIRCULATION; BLEEDING; BLOOD CLOTTING DISORDER; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CARDITIS; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; COMA; CONGENITAL HEART DISEASE; DEBRIDEMENT; EUROPEAN AMERICAN; FEMALE; HEART ASSIST DEVICE; HEART RIGHT VENTRICLE FAILURE; HEART TAMPONADE; HEMOLYSIS; HUMAN; IATROGENIC DISEASE; IDIOPATHIC CARDIOMYOPATHY; IDIOPATHIC DISEASE; ISCHEMIC CARDIOMYOPATHY; KIDNEY FAILURE; LEFT VENTRICULAR ASSIST DEVICE; LIVER DISEASE; LUNG INFECTION; MAJOR CLINICAL STUDY; MALE; MECHANICAL CIRCULATORY SUPPORT; MEDIASTINUM DISEASE; MORTALITY; OUTCOME ASSESSMENT; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE INFECTION; PREDICTIVE VALUE; PRIORITY JOURNAL; REOPERATION; RESPIRATORY TRACT DISEASE; RESPIRATORY TRACT INTUBATION; RETROSPECTIVE STUDY; RISK ASSESSMENT; SEIZURE; SURVIVAL RATE; THROMBOEMBOLISM; TRACHEOSTOMY; TRANSIENT ISCHEMIC ATTACK; WOUND DEHISCENCE; EQUIPMENT DESIGN; HEART FAILURE; HEART TRANSPLANTATION; INFECTION; KIDNEY DISEASE; MIDDLE AGED; RISK FACTOR; STATISTICS; TREATMENT FAILURE; TREATMENT OUTCOME;

ADULT; AGED; COHORT STUDIES; EQUIPMENT DESIGN; FEMALE; HEART FAILURE; HEART TRANSPLANTATION; HEART-ASSIST DEVICES; HEMORRHAGE; HUMANS; INFECTION; KIDNEY DISEASES; MALE; MIDDLE AGED; RESPIRATORY TRACT DISEASES; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TREATMENT FAILURE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79952111377     PISSN: 10532498     EISSN: 15573117     Source Type: Journal    
DOI: 10.1016/j.healun.2010.04.014     Document Type: Article

References (45)

1. Goldstein DJ, Oz MC, Rose EA. Implantable left ventricular assist devices. N Engl J Med 1998;339:1522-33. (Pubitemid 28543502)
2. Frazier OH, Rose EA, Oz MC, et al. Multicenter clinical evaluation of the HeartMate vented electric left ventricular assist system in patients awaiting heart transplantation. J Thorac Cardiovasc Surg 2001;122: 1186-95.
3. Miller LW, Pagani FD, Russell SD, et al. Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med 2007; 357:885-96. (Pubitemid 47347322)
4. John R, Kamdar F, Liao K, Colvin-Adams M, Boyle A, Joyce L. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy. Ann Thorac Surg 2008;86:1227-34; discussion 34-5.
5. Lahpor J, Khaghani A, Hetzer R, et al. European results with a continuous-flow ventricular assist device for advanced heart-failure patients. Eur J Cardiothorac Surg 2010;37:357-61.
6. Chen JM, Spanier TB, Gonzalez JJ, et al. Improved survival in patients with acute myocarditis using external pulsatile mechanical ventricular assistance. J Heart Lung Transplant 1999;18:351-7. (Pubitemid 29205271)
7. Simon MA, Kormos RL, Murali S, et al. Myocardial recovery using ventricular assist devices: prevalence, clinical characteristics, and outcomes. Circulation 2005;112:I32-6. (Pubitemid 41266650)
8. Rose EA, Gelijns AC, Moskowitz AJ, et al. Long-term mechanical left ventricular assistance for end-stage heart failure. N Engl J Med 2001; 345:1435-43.
9. Park SJ, Tector A, Piccioni W, et al. Left ventricular assist devices as destination therapy: a new look at survival. J Thorac Cardiovasc Surg 2005;129:9-17. (Pubitemid 40038090)
10. Stevenson LW, Miller LW, Desvigne-Nickens P, et al. Left ventricular assist device as destination for patients undergoing intravenous inotropic therapy: a subset analysis from REMATCH (Randomized Evaluation of Mechanical Assistance in Treatment of Chronic Heart Failure). Circulation 2004;110:975-81. (Pubitemid 39128623)
11. Rogers JG, Butler J, Lansman SL, et al. Chronic mechanical circulatory support for inotrope-dependent heart failure patients who are not transplant candidates: results of the INTrEPID Trial. J Am Coll Cardiol 2007;50:741-7. (Pubitemid 47239315)
12. Slaughter MS, Rogers JG, Milano CA, et al. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med 2009.
13. Deng MC, Loebe M, El-Banayosy A, et al. Mechanical circulatory support for advanced heart failure: effect of patient selection on outcome. Circulation 2001;103:231-7. (Pubitemid 32095408)
14. Holman WL, Kormos RL, Naftel DC, et al. Predictors of death and transplant in patients with a mechanical circulatory support device: a multi-institutional study. J Heart Lung Transplant 2009;28:44-50.
15. Holman WL, Pae WE, Teutenberg JJ, et al. INTERMACS: interval analysis of registry data. J Am Coll Surg 2009;208:755-61; discussion 61-2.
16. Lietz K, Long JW, Kfoury AG, et al. Outcomes of left ventricular assist device implantation as destination therapy in the post- REMATCH era: implications for patient selection. Circulation 2007; 116:497-505. (Pubitemid 47450258)
17. Rao V, Oz MC, Flannery MA, Catanese KA, Argenziano M, Naka Y. Revised screening scale to predict survival after insertion of a left ventricular assist device. J Thorac Cardiovasc Surg 2003;125:855-62. (Pubitemid 36457507)
18. Dang NC, Topkara VK, Mercando M, et al. Right heart failure after left ventricular assist device implantation in patients with chronic congestive heart failure. J Heart Lung Transplant 2006;25:1-6. (Pubitemid 43049657)
19. Kavarana MN, Pessin-Minsley MS, Urtecho J, et al. Right ventricular dysfunction and organ failure in left ventricular assist device recipients: a continuing problem. Ann Thorac Surg 2002;73:745-50. (Pubitemid 34188307)
20. Sandner SE, Zimpfer D, Zrunek P, et al. Renal function and outcome after continuous flow left ventricular assist device implantation. Ann Thorac Surg 2009;87:1072-8.
21. McBride LR, Naunheim KS, Fiore AC, et al. Risk analysis in patients bridged to transplantation. Ann Thorac Surg 2001;71:1839-44. (Pubitemid 32554411)
22. Topkara VK, Dang NC, Barili F, et al. Predictors and outcomes of continuous veno-venous hemodialysis use after implantation of a left ventricular assist device. J Heart Lung Transplant 2006;25:404-8.
23. Genovese EA, Dew MA, Teuteberg JJ, et al. Incidence and patterns of adverse event onset during the first 60 days after ventricular assist device implantation. Ann Thorac Surg 2009;88:1162-70.
24. Esmore D, Kaye D, Spratt P, et al. A prospective, multicenter trial of the VentrAssist left ventricular assist device for bridge to transplant: safety and efficacy. J Heart Lung Transplant 2008;27:579-88.
25. Sharples LD, Cafferty F, Demitis N, et al. Evaluation of the clinical effectiveness of the Ventricular Assist Device Program in the United Kingdom (EVAD UK). J Heart Lung Transplant 2007;26:9-15. (Pubitemid 46096740)
26. Argenziano M, Catanese KA, Moazami N, et al. The influence of infection on survival and successful transplantation in patients with left ventricular assist devices. J Heart Lung Transplant 1997;16:822-31. (Pubitemid 27362682)
27. Simon D, Fischer S, Grossman A, et al. Left ventricular assist devicerelated infection: treatment and outcome. Clin Infect Dis 2005;40: 1108-15. (Pubitemid 40490234)
28. Schulman AR, Martens TP, Russo MJ, et al. Effect of left ventricular assist device infection on post-transplant outcomes. J Heart Lung Transplant 2009;28:237-42.
29. Bhama JK, Rayappa S, Zaldonis D, et al. Impact of abdominal complications on outcome after mechanical circulatory support. Ann Thorac Surg 2010;89:522-8; discussion 8-9.
30. Interagency Registry for Mechanically Assisted Circulatory Support. http://www.intermacs.org/. Accessed: Dec 1, 2009.
31. Zahr F, Ootaki Y, Starling RC, et al. Preoperative risk factors for mortality after biventricular assist device implantation. J Card Fail 2008;14:844-9.
32. Kanter KR, Swartz MT, Pennington DG, et al. Renal failure in patients with ventricular assist devices. ASAIO Trans 1987;33:426-8.
33. Kaltenmaier B, Pommer W, Kaufmann F, Hennig E, Molzahn M, Hetzer R. Outcome of patients with ventricular assist devices and acute renal failure requiring renal replacement therapy. ASAIO J 2000;46: 330-3. (Pubitemid 30308130)
34. Bhama JK, Kormos RL, Toyoda Y, Teuteberg JJ, McCurry KR, Siegenthaler MP. Clinical experience using the Levitronix CentriMag system for temporary right ventricular mechanical circulatory support. J Heart Lung Transplant 2009;28:971-6.
35. Pagani FD, Miller LW, Russell SD, et al. Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device. J Am Coll Cardiol 2009;54:312-21.
36. McKenna DH Jr, Eastlund T, Segall M, Noreen HJ, Park S. HLA alloimmunization in patients requiring ventricular assist device support. J Heart Lung Transplant 2002;21:1218-24. (Pubitemid 35300469)
37. Sihler KC, Napolitano LM. Complications of massive transfusion. Chest 2010;137:209-20.
38. Asadollahi K, Beeching NJ, Gill GV. Leukocytosis as a predictor for non-infective mortality and morbidity. QJM 2010;103:285-92.
39. Forman DE, Butler J, Wang Y, et al. Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure. J Am Coll Cardiol 2004;43:61-7. (Pubitemid 38045917)
40. Hillege HL, Girbes AR, de Kam PJ, et al. Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Circulation 2000;102:203-10. (Pubitemid 30451778)
41. Russell SD, Rogers JG, Milano CA, et al. Renal and hepatic function improve in advanced heart failure patients during continuous-flow support with the HeartMate II left ventricular assist device. Circulation 2009;120:2352-7.
42. Sandner SE, Zimpfer D, Zrunek P, et al. Renal function after implantation of continuous versus pulsatile flow left ventricular assist devices. J Heart Lung Transplant 2008;27:469-73. (Pubitemid 351602173)
43. Radovancevic B, Vrtovec B, de Kort E, Radovancevic R, Gregoric ID, Frazier OH. End-organ function in patients on long-term circulatory support with continuous- or pulsatile-flow assist devices. J Heart Lung Transplant 2007;26:815-8. (Pubitemid 47199072)
44. James KB, McCarthy PM, Jaalouk S, et al. Plasma volume and its regulatory factors in congestive heart failure after implantation of long-term left ventricular assist devices. Circulation 1996;93:1515-9. (Pubitemid 26115416)
45. Gaudino M, Luciani N, Giungi S, et al. Different profiles of patients who require dialysis after cardiac surgery. Ann Thorac Surg 2005;79: 825-9; author reply 9-30. (Pubitemid 40288728)